← Leaderboards
Diana Zepeda-Orozco
Research Inst Nationwide Children'S Hosp
$2,467,120
Attributed
$2,467,120
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,467,120 · 2
By mechanism
R01$2,467,120 · 2
Top collaborators
No co-investigators on record.
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Ruoning Wang$11,278,033
- Craig Lawrence Kien$9,434,862
Others in their field
Other Rising Stars on “Malignant Neoplasms”
- David Annett · Information Management Services, Inc.$35,571,865
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jon White · Midwest Research Institute$17,594,074
- Carolina Porras · Fundacion Inciensa$10,814,023
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
Research focus
Malignant NeoplasmsOxidative DamageHydrogen PeroxideKidneyMimeticsNovel DiagnosticsEpidermal Growth FactorFutureInjury To KidneyIn VivoAcuteMediatingMitochondriaNephrotoxicityClinical Trials DesignDetection LimitBiological MarkersFibrosisInflammationInjuryInnovationChronic Kidney FailureCisplatinOxidative Stress
Grant awards (4)
Targeting Tubular Mitochondrial Superoxide Dismutation in Cisplatin Renal Repair$610,987
R01 · FY2025 · DK · contact PI
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors$599,573
R01 · FY2025 · CA · contact PI
Targeting Tubular Mitochondrial Superoxide Dismutation in Cisplatin Renal Repair$628,987
R01 · FY2024 · DK · contact PI
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors$627,573
R01 · FY2024 · CA · contact PI